CRBP
NASDAQ
$8.89
Corbus Pharmaceuticals Holdings Inc (CRBP)
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target the endocannabinoid system in the fields of autoimmunity, fibrosis, and cancer. The company is headquartered in Norwood, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $35.30 (+297.08%)
Market Cap
$160M
Free Cash Flow Yield
-46.08%
Beta (5Y)
1.20
Price Chart
Valuation
Market Cap$160M
P/S169.88
P/B1.33
Profitability
Total Revenue (TTM)$5.25M
Gross Profit (TTM)-$74M
EBITDA-$90M
EPS-$5.77
Financial Health
Free Cash Flow Yield-46.08%
Growth & Risk
EPS 5Y CAGR-33.12%
Revenue 5Y CAGR+5.98%
FCF 5Y CAGR-6.63%
Beta (5Y)1.20
Sharpe Ratio0.43